Agilent Companion Diagnostic Gains Expanded FDA Approval in Cervical Cancer

Agilent Companion Diagnostic Gains Expanded FDA Approval in Cervical Cancer PD-L1 IHC 22C3 pharmDx can now be used as an aid to identify cervical cancer patients for treatment with KEYTRUDA® (pembrolizumab) SANTA CLARA, Calif., June 12, 2018 Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration (FDA) has approved its... Read more

Merck KGaA, Darmstadt, Germany Provides Update on Tepotinib Phase II Results in Advanced Hepatocellular Carcinoma

Primary endpoints met in two clinical trials for investigational targeted therapy, tepotinib, as a monotherapy in MET-positive, advanced hepatocellular carcinoma (HCC) with Child-Pugh Class A liver function These data provide further evidence of tepotinib activity in patients with MET-positive advanced cancers Given evolving standard of care in HCC, Merck KGaA, Darmstadt, Germany will assess the... Read more

Merck KGaA, Darmstadt, Germany Drives Thought Leadership in Ethical Gene Editing

Co-authored paper, “Ethical Considerations in the Manufacture, Sale and Distribution of Genome-Editing Technologies,” accepted in leading bioethics journal Highlights importance of science-based bioethics in genome editing and novel processes to ensure products meet the highest standards  Darmstadt, Germany, June 12, 2018 – Merck KGaA, Darmstadt, Germany, a leading science and technology company and leader in... Read more

Agilent Enables CISH on Dako Omnis

Agilent Enables CISH on Dako Omnis System can now employ three analytical techniques simultaneously SANTA CLARA, Calif., June 12, 2018 Agilent Technologies Inc. (NYSE: A) today announced the release of a new accessory kit that enables the company’s Dako Omnis system to analyze tissue samples using three different techniques simultaneously. With the new kit, the... Read more

Bruker Introduces New SKYSCAN 2214 Ultra-High Resolution Nano-CT

BILLERICA, Mass., June 12, 2018 /PRNewswire/ — Bruker today announced the launch of the SKYSCAN™ 2214, a multiscale X-ray nano-CT (computed tomography) system with a unique X-ray source and detector geometry that generates sharper images with outstanding precision. The SKYSCAN 2214 offers unprecedented, ultra-high resolution for larger fields of view in larger objects, which makes nano-CT... Read more

Bruker Launches the S6 JAGUAR™ Benchtop WDXRF System for Elemental Analysis in Industry and Academia

FRANKFURT, Germany, June 11, 2018 /PRNewswire/ — At ACHEMA 2018, Bruker today announces the launch of the new S6 JAGUAR™, an exceptionally powerful and versatile benchtop Wavelength Dispersive X-Ray Fluorescence (WDXRF) spectrometer. The S6 JAGUAR extends Bruker’s range of XRF instruments by closing the gap between floor standing WDXRF and benchtop EDXRF instruments. It combines excellent... Read more

Phenomenex Opens Office for Sales and Support in Singapore

Torrance, Calif. (June 7, 2018) – Phenomenex, Inc., a global leader in the research and manufacturer of advanced technologies for the separation sciences, announced today that it has opened an office to directly serve customers in Singapore. Phenomenex has been doing business in Singapore through distributors since 1993. Direct presence allows Phenomenex to provide customers... Read more

Bruker Announces Improved Solutions for Microbial Strain Typing, Hospital Hygiene and Infection Control, and Candida auris Testing at ASM 2018

– Improved IR Biotyper™ system for fast, routine and cost-effective strain typing for hospital infection control and earlier detection of outbreaks – FDA clearance for Candida auris identification with the MALDI Biotyper® to support better diagnostics and monitoring in critically ill patients ATLANTA, June 7, 2018 /PRNewswire/ — At the American Society for Microbiology (ASM) Microbe... Read more

Merck KGaA, Darmstadt, Germany Completes Third and Final Registration Phase under the European Chemicals Regulation REACH

June 6, 2018 Your Contact: Gangolf Schrimpf +49 6151 72-9591 Merck KGaA, Darmstadt, Germany Completes Third and Final Registration Phase under the European Chemicals Regulation REACH More than 1,000 registration dossiers successfully submitted for safe use Darmstadt, Germany, June 6, 2018 — Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that it... Read more